Previous Article | Next Article ![]()
Infection and Immunity, July 2004, p. 3876-3882, Vol. 72, No. 7
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.7.3876-3882.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, The Nippon Dental University School of Dentistry at Tokyo, 1-9-20 Fujimi, Chiyoda-ku, Tokyo 102-8159, Japan,1 Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892-43522
Received 7 January 2004/ Returned for modification 18 February 2004/ Accepted 31 March 2004
|
|
|---|
|
|
|---|
The hsa gene encodes a large (203-kDa) serine-rich repeat protein composed of 2,178 amino acid residues. The predicted protein sequence includes an N-terminal nonrepetitive region (NR1), a serine-rich repeat region (SR1), another nonrepetitive region (NR2), another serine-rich repeat region (SR2), and a C-terminal cell wall anchoring domain. Most of NR1 consists of a putative signal sequence, and this region along with SR1 and NR2 comprises the first 450 amino acid residues of the Hsa sequence. The remainder of this sequence includes SR2, which contains more than 100 dodecapeptide repeats with the consensus sequence SASTSASVSASE, and the cell wall anchoring domain (23). Serine-rich repeat proteins also occur on other viridans group streptococci; these proteins include Fap1 of Streptococcus parasanguinis, which mediates bacterial adhesion to saliva-coated hydroxyapatite (29), and GspB of S. gordonii M99, which mediates bacterial binding of human platelets (1). The occurrence of the latter interaction raises the possibility that serine-rich repeat proteins play a role in the pathogenesis of streptococcus-induced infective endocarditis, which is thought to involve platelet-streptococcus interactions (8). The structural specificity of these interactions is not yet known.
It has previously been suggested that the putative sialic acid-binding domain of Hsa is associated with the N-terminal region of the protein, through NR2, and that this domain is presented on the bacterial surface at the end of a long molecular stalk formed by SR2 (23). To assess this model, in this study we examined hsa constructs that specifically lack the coding regions for SR1, NR2, or SR2 in order to determine their abilities to restore Hsa-mediated adhesion of an hsa deletion mutant of strain DL1. In addition, by using genetic complementation we found that the biological role of Hsa-mediated adhesion extends to the aggregation of human platelets, thereby raising the possibility that sialic acid-binding adhesins of oral viridans group streptococci contribute not only to oral colonization but also to the pathogenesis of infective endocarditis.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. S. gordonii strains and plasmids
|
|
View this table: [in a new window] |
TABLE 2. PCR-amplified DNA fragments and adapter used for preparation of hsa deletion constructs
|
![]() View larger version (16K): [in a new window] |
FIG. 1. Alignment of the physical map of the 7.4-kb HindIII-SphI fragment of S. gordonii DL1 chromosomal DNA in pAS8741 with the nonrepetitive regions (NR1 and NR2), serine-rich repetitive regions (SR1 and SR2), and cell wall anchoring domain (CWAD) of the encoded Hsa protein. a.a, amino acid.
|
![]() View larger version (23K): [in a new window] |
FIG. 2. Restoration of Hsa-mediated adhesion by genetic complementation of S. gordonii CM100 with plasmids expressing hsa (i.e., pAS8741) or hsa deletion constructs. The positions of the nonrepetitive regions (NR1 and NR2), serine-rich repetitive regions (SR1 and SR2), and cell wall anchoring domain (CWAD) of Hsa are indicated above the diagram of the complete protein encoded by pAS8741. The V-shaped lines indicate the regions removed from recombinant proteins by in-frame deletions in plasmid-borne hsa. The hemagglutinating activity of each plasmid-bearing transformant is expressed relative to that of CM100(pAS8741). Bacterial binding to immobilized sialoglycoconjugates is indicated by a plus or minus sign.
|
Dot immunoblotting was performed to detect Hs antigen on bacterial cells. Nitrocellulose membranes were spotted with 1 µl of each streptococcal cell suspension (1 x 109 cells per ml), blocked, incubated with primary antibody or biotinylated WGA, and developed with peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) (Bio-Rad Laboratories, Richmond, Calif.) or avidin D-horseradish peroxidase (Vector Laboratories, Inc., Burlingame, Calif.), respectively, as previously described (25).
Bacteria harvested from cultures in the logarithmic phase of growth were digested with mutanolysin (Sigma-Aldrich) in the presence of raffinose (26%, wt/vol) as previously described (4). Solubilized cell wall proteins and protoplasts were collected in separate fractions following centrifugation of each digest. The spent culture medium was also collected, filtered to remove residual bacteria, and concentrated by ultrafiltration by using a Vivapore 10/20 concentrator (Vivascience Limited, Gloucestershire, United Kingdom). Bacterial antigens were also prepared by sonication of streptococci as previously described (23, 25). The protein concentrations in all samples were determined by using the bicinchoninic acid protein assay reagent (Pierce, Rockford, Ill.). Samples were boiled for 10 min in reducing sample buffer, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) by using 5 or 10% polyacrylamide gels (12), and electrophoretically transferred to nitrocellulose membranes (27) for Western blotting with anti-Hs (1:100 dilution) or for lectin overlay analysis with WGA-biotin (50 µg/ml) as previously described (25).
Bacterial adhesion.
Bacterium-mediated hemagglutination was performed as previously described (25) by mixing serial dilutions of each transformant, starting with 1 x 109 bacteria per ml, with a constant amount of human type O RBC. The relative hemagglutinating activity of each plasmid-bearing transformant was calculated with respect to the hemagglutinating activity of strain CM100 harboring pAS8741, which exhibited an endpoint titer of 1:32. Adhesion of NHS-LC-biotin (Pierce)-labeled bacteria to sialoglycoconjugates immobilized on nitrocellulose has also been described previously (25). The glycoconjugates tested as adhesion receptors included fetuin (Sigma-Aldrich) and NeuAc
2-3Galß1-4(Glc)-HSA (Accurate Chemical and Scientific Corp., Westbury, N.Y.), a neoglycoprotein prepared by conjugation of the reduced oligosaccharide to human serum albumin through an acetylphenylenediamine spacer.
The platelet bacterial adhesion assay (2, 9) was performed by mixing 50 µl of washed platelets (5 x 108 platelets/ml) with 50 µl of bacterial suspension (2 x 109 cells/ml) in individual wells of microtiter plates. Supernatants containing unaggregated bacteria and platelets were harvested following low-speed centrifugation (35 x g) and were diluted 1:2 prior to measurement of A620. The platelets utilized in these assays were harvested by centrifugation of platelet-rich plasma from citrated type O blood and were washed with Tris-buffered saline (TBS) containing 10 mM EDTA or 0.1 mM CaCl2. Adhesion assays were also performed with platelets that were washed following treatment with 1 U of type X neuraminidase from Clostridium perfringens (Sigma-Aldrich) per ml for 30 min at 37°C to remove sialic acid.
|
|
|---|
Expression of hsa constructs that lacked the coding regions for SR1 and/or NR2 failed to restore adhesion. Transformants harboring these plasmids (pAS8748, pAS8744, and pAS8746) lacked hemagglutinating activity and failed to bind immobilized sialoglycoconjugates (Fig. 2). Each transformant did, however, react with anti-Hs (Fig. 3), suggesting that there was surface expression of an immunoreactive protein. Such proteins also were readily detected by Western blotting of concentrated culture supernatants (results not shown), as well as cell wall and protoplast proteins prepared by mutanolysin digestion of the transformants (Fig. 4). However, the electrophoretic mobilities of these proteins were similar and indistinguishable from the mobility of full-length Hsa produced by wild-type strain DL1 or strain CM100 harboring pAS8741. In all cases, the major band of anti-Hs immunoreactive protein migrated above the 250-kDa marker, near the top of the 5% gel (Fig. 4), rather than in the 180- to 200-kDa region expected based on the gene sequences of the various constructs examined (Fig. 2).
![]() View larger version (43K): [in a new window] |
FIG. 3. Binding of anti-Hs (1:100), WGA-biotin (50 µg/ml), and anti-DL1 (1:1,000) to S. gordonii CM100 harboring different plasmids. Wild-type strain DL1 and the hsa insertional mutant strain EM230 were also included. Washed bacteria were spotted on three separate nitrocellulose membranes. Each membrane was incubated with primary antibody followed by peroxidase-conjugated goat anti-rabbit IgG or with WGA-biotin followed by avidin. The membrane labeled with anti-DL1 was included as a positive control for each strain.
|
![]() View larger version (38K): [in a new window] |
FIG. 4. Western and lectin blotting of streptococcal cell wall (CW) and protoplast (PP) proteins of S. gordonii DL1 and strain CM100 harboring different plasmids. The material in each sample was obtained from 1 ml of bacterial culture. Sonic extracts (Sonic) (50 µg of total protein/lane) of CM100(pAS8165), CM100(pAS8164), and CM100(pAS40S) were also examined. SDS-PAGE was performed with 5% polyacrylamide gels (upper panels) or 10% polyacrylamide gels (lower panels). Nitrocellulose transfers were incubated with anti-Hs (1:100) followed by peroxidase-conjugated goat anti-rabbit IgG or with WGA-biotin (50 µg/ml) followed by avidin. The boundary between the stacking and separating gels (asterisk) and the positions of molecular mass markers are indicated on the left.
|
Plasmid pAS8165, obtained by removal of the entire coding region for SR2, did not restore Hsa-mediated adhesion in strain CM100 (Fig. 2). Anti-Hs reacted weakly or not at all with CM100(pAS8165) (Fig. 3) and with the cell wall proteins solubilized by mutanolysin digestion of this transformant (Fig. 4), indicating that surface-expressed recombinant Has was absent. The protoplast fraction and sonic extract prepared from this transformant did, however, contain recombinant Hsa (Fig. 4). The major immunoreactive protein migrated with the 75-kDa marker, significantly above the calculated molecular mass (52 kDa).
Plasmid pAS8164, which lacked the coding regions for both SR1 and SR2, also failed to restore Hsa-mediated adhesion (Fig. 2). An anti-Hs immunoreactive protein, although not detected on the surface of CM100(pAS8164) (Fig. 3 and 4), was detected as a faint band in the protoplast fraction and more strongly in a sonic extract of this transformant (Fig. 4). A similar band was not observed in the corresponding control sonic extract prepared from strain CM100 harboring pAS40S, which lacked hsa. The recombinant Hsa protein encoded by pAS8164 migrated slightly above the 37-kDa marker, near the position expected based on the predicted sequence of Hsa lacking both serine-rich regions.
Hsa-specific glycosylation detected by binding of WGA. The previously observed reaction of WGA with the Hs antigen of S. gordonii DL1 prompted further consideration of this GlcNAc-binding lectin as a possible probe for Hsa-specific glycosylation. WGA reacted specifically with each strain that surface expressed Hsa (Fig. 3) and with solubilized wild-type and recombinant Hsa that lacked SR1, NR2, or SR2 (Fig. 2 and 4) (the recombinant proteins produced from pAS8744, pAS8746, and pAS8765, respectively). This lectin also reacted with recombinant Hsa produced from pAS8748, which lacked SR1 and NR2, and with the proteins encoded by pAS8749 and pAS8375, which lacked portions of SR2 (results not shown). However, recombinant Hsa that lacked both SR1 and SR2 (i.e., the protein produced from pAS8164) failed to react with WGA. This protein was detected by Western blotting with anti-Hs in the sonic extract of CM100(pAS8164) and was not detected following incubation of an identical transfer with WGA (Fig. 4). Thus, binding of WGA appeared to involve the serine-rich regions of Hsa.
Role of Hsa in bacterial adhesion to human platelets. The recent finding that GspB, the serine-rich repeat protein of S. gordonii M99, mediates the adhesion of this strain to human platelets (1) prompted us to examine the possible role of Hsa in platelet binding. Strong aggregation occurred when S. gordonii DL1 was mixed with human platelets (Fig. 5A). This interaction was noted in both EDTA- and Ca2+-containing buffers but not following pretreatment of the platelets with neuraminidase (Fig. 5B). In identical assays, strain EM230, an hsa insertional mutant, and strain CM100 harboring control plasmid pAS40S failed to interact with platelets (Fig. 5). Significantly, platelet-aggregating activity was fully restored in strain CM100 by expression of hsa from plasmid pAS8741 (Fig. 5), firmly establishing the role of this gene and its encoded protein in the bacterium-platelet interaction.
![]() View larger version (69K): [in a new window] |
FIG. 5. Essential role of Hsa in adhesion of S. gordonii DL1 to human platelets. (A) Microtiter wells containing washed platelets and bacteria, showing visible aggregation in wells containing bacteria that surface express Hsa (wild-type strain DL1 and strain CM100 harboring pAS8741) and no aggregation in wells containing bacteria that do not produce Hsa (strain EM230, an hsa insertional mutant, and strain CM100 harboring control plasmid pAS40S). (B) Aggregation of untreated platelets in TBS-EDTA (U) (cross-hatched bars) or in TBS-Ca2+ (C) (open bars) and aggregation of neuraminidase-treated platelets (N) (solid bars).
|
|
|
|---|
The finding that WGA reacted with recombinant proteins that lacked SR1, NR2, or SR2 but not with the recombinant protein that lacked both SR1 and SR2 strongly suggests that the serine-rich regions of Hsa are glycosylated. This possibility is also consistent the anomalous migration of Hsa in SDS-PAGE, which was observed with recombinant proteins that contained either SR1 or SR2 but not with the recombinant protein encoded by pAS8164, which lacked both serine-rich regions. Glycosylation of the serine-rich regions in another serine-rich repeat protein, Fap1 of S. parasanguinis, has also been suggested by the results of a comparative carbohydrate analysis of this protein and a Fap1 glycopeptide (22). Likewise, the previously observed binding of WGA to a fimbrial glycoprotein of Streptococcus salivarius (13) is of interest since this reaction may involve glycosylated peptide repeats similar to those found in Hsa. Extensive O glycosylation, like that noted for mucin-type glycoproteins (3, 7), may confer an extended rod-shaped conformation on the serine-rich regions of Hsa, especially SR2, which would enable this region to function as a molecular stalk for cell surface presentation of the putative receptor binding domain.
The synthesis and export of GspB, the serine-rich repeat protein of S. gordonii M99, depend on an accessory sec locus immediately downstream of gspB (1) (Fig. 6). Interestingly, a similar locus occurs downstream of hsa (Fig. 6), as shown by analysis of this region obtained from the genomic database for S. gordonii Challis (i.e., DL1) available at The Institute of Genomic Research website (http://www.tigr.org/tdb/mdb/mdbinprogress.html). The only significant difference between these regions in the two strains that has been found involves the gene identified as gly in strain M99, which encodes a putative glycosyltransferase. In strain M99, this gene appears to be complete, while in strain Challis it is interrupted by deletion of a single adenine at position 1083 of the complete 2,049-bp sequence, which gives rise to a terminator codon 133 nucleotides downstream of the deletion. Thus, while gly may have a role in GspB synthesis, the truncated gene in strain DL1, which was previously designated ORF4 (23), is most likely inactive. Indeed, the deletion of hsa and virtually all the gly-related sequence from strain CM100, which lacks a 9.2-kb HindIII fragment of chromosomal DNA (Fig. 6), is complemented by pAS8741 (Fig. 1), which contains hsa and only 0.2 kb of the gly-related sequence. In strain M99, two genes further downstream, secY2 and secA2, encode proteins that function in the specific export of GspB. Disruption of either gene eliminated surface expression of GspB, resulting in accumulation of this protein in the cytoplasm (1). Interestingly, the recombinant protein encoded by pAS8165, which lacked SR2 (Fig. 2), also accumulated in the cytoplasm, raising the possibility that this region contains the signal for secY2-secA2-dependent export of Hsa from strain DL1.
|
View larger version (11K): [in a new window] |
FIG. 6. Comparison of the accessory sec locus downstream of gspB in S. gordonii M99 (1) with a similar locus downstream of hsa in S. gordonii Challis (i.e., strain DL1). Nucleotide sequence identities between corresponding genes were calculated with the program BESTFIT (GCG Wisconsin package). The deletion mutant strain CM100, which was used in genetic complementation studies, lacked the 9.2-kb HindIII fragment identified in the open reading frame diagram of strain Challis.
|
2-3-linked sialic acid termini of O-glycosylated mucin-type glycoproteins, including salivary mucin MG2 (23, 24, 25) and leukosialin, the major surface glycoprotein of human polymorphonuclear leukocytes (19). Significantly, the major surface glycoprotein of human platelets, GP1b, also contains sialylated mucin-like domains (28), making this component a potential receptor for sialic acid-binding bacterial adhesins. In previous studies (11), bacterium-mediated hemagglutinating activity was observed with 41 of 48 S. sanguinis, S. gordonii, and S. oralis strains, and in virtually all cases pretreatment of the RBC with neuraminidase eliminated these interactions. Interestingly, the interactions between these bacteria and RBC from different mammalian species were not identical but instead varied from strain to strain in a manner similar to that noted in early studies of viral hemagglutinins that bind different sialic acid-containing structures (14). Moreover, representative streptococcal strains that possessed hemagglutinating activity varied widely in their reactions with specific antibody against the Hs antigen of strain DL1 (25). These observations suggest that there is heterogeneity among the sialic acid-binding adhesins of these bacteria, both in terms of their receptor binding specificities and in terms of their antigenic properties. Further studies are needed to determine whether these adhesins are associated with different but structurally related serine-rich repeat proteins and, if so, whether there are differences in the interactions of individual proteins with sialoglycoconjugate receptors on oral surfaces, neutrophils (19), and human platelets. The results of such studies may provide important insights into the pathogenesis of infective endocarditis induced by oral viridans group streptococci.
This work was supported by grant-in-aid for scientific research 12771098 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
|
|
|---|
2,3Galß1,3GalNAc sequence. Biochem. Biophys. Res. Commun. 106:390-396.[CrossRef][Medline]
2-3-linked sialic acid-containing receptors. Infect. Immun. 65:5042-5051.[Abstract]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»